Archives of Pulmonology and Respiratory Care
Case Report
Different Levels of Exhaled Nasal Nitric Oxide in Patients Diagnosed with Primary Dyskinesia
http://www.peertechz.com/Pulmonology-Respiratory-Care/pdf/APRC-1-104.pdf
Case Report
Different Levels of Exhaled Nasal Nitric Oxide in Patients Diagnosed with Primary Dyskinesia
Background: Primary ciliary dyskinesia (PCD) is a genetic disease characterized
by abnormally beating cilia. In these
patients levels of nasal nitric oxide (nNO) are lower than those observed in
healthy subjects.
Objectives: We recorded the nNO levels in PCD patients in order to use those
nNO measurements in the screening and identification of patients with symptoms
suggestive of disease PCD disease.
Methods: We measured nasal NO in 36 PCD patients (3 uncooperative younger
children and 33 cooperative adult patients) and did a nNO re-evaluation after
12 months in patients with higher levels of nNO.
Results: Twenty-seven PCD patients showed very low nNO levels (29.1 ppb) and
nine cooperative patients had high nNO levels (583.3 ppb, p<0.001) (T0); the
PCD patients with high nNO levels were re-evaluated after 12 months (T1).
The median T0 and T1 nNO values of the seven
PCD patients were 360 ppb and 324 ppb (p=0.0180), respectively; in 6 patients
with high levels of nNO the diagnosis of PCD was confirmed by electron
microscopy, and in one subject the diagnosis was confirmed for secondary
ciliary dyskinesia.
Conclusions: Low levels of nNO remain indicative of PCD disease; high levels of
nNO are supportive of PCD, but cannot be used to exclude diagnosis.
These
results suggest that repeated measures are warranted when nNO is occasionally
high in patients with symptoms suggestive of PCD disease, and at present
electron microscopy is still the only valid evaluation tool in unclear cases of
PCD.http://www.peertechz.com/Pulmonology-Respiratory-Care/pdf/APRC-1-104.pdf
Comments
Post a Comment